Tag: Brian Hood

Browse our exclusive articles!

Exploring the Limits of Artificial Intelligence: Is AI Capable of Committing Libel?

Recent news has sparked debates about AI's ability to commit libel. With the development of generative AI, it raises the question of whether AI models, like ChatGPT, should be held liable for producing content that appears indistinguishable from reality. OpenAI, a technology company founded by Elon Musk and Sam Altman, have been called on to take action by the mayor of Hepburn Shire in Australia, Brian Hood, whose name had been falsely claimed to have been convicted of a crime from 20 years ago. Legal and tech experts tackle the rising issue of AI-powered platforms to ensure that false or damaging statements do not arise.

AI Liability: Is Legal Action Possible?

ChatGPT: AI technology has been rapidly making headlines in recent months, ranging from chatbot application ChatGPT reaching 100 million users in two months to a federal copyright lawsuit being issued against art-generating AI tools. The recent ChatGPT defamation scandal has also sparked public interest, with false allegations of Brian Hood's prison sentence due to bribery charges being revealed as lies. OpenAI release of the upgraded GPT-4 update seeks to improve accuracy levels.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img